maitalon 20/21+7 0,02 mg/3 mg filmtabletten
maitalon 30/21+7 0,03 mg/3 mg filmtabletten
maitalon 20 0,02 mg/3 mg filmtabletten
maitalon 30 0,03 mg/3 mg filmtabletten
kisqali 200 mg
novartis israel ltd - ribociclib as succinate - film coated tablets - ribociclib as succinate 200 mg - ribociclib - kisqali is indicated in combination with:* a non-steroid aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women, with hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer, as initial endocrine-based therapy.or* fulvestrant for the treatment of men and postmenopausal women with hr-positive, her2-negative advanced or metastatic breast cancer, as initial endocrine based therapy or following disease progression on endocrine therapy.
citalon 20 mg filmtabletten
citalon 40 mg filmtabletten
citalopram al 40 mg filmtabletten
citalopram al 20 mg filmtabletten
citalopram al 10 mg filmtabletten